Advanced Search

    Technical Analysis for MYMD - MyMD Pharmaceuticals, Inc.

    Grade Last Price % Change Price Change
    F 1.72 1.18% 0.02
    MYMD closed up 1.18 percent on Friday, March 31, 2023, on 1.13 times normal volume.
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Up
    Historical MYMD trend table...
    Date Alert Name Type % Chg
    Narrow Range Bar Range Contraction 0.00%
    Wide Bands Range Expansion 0.00%
    20 DMA Resistance Bearish 1.18%
    50 DMA Resistance Bearish 1.18%
    Shooting Star Candlestick Bearish 1.18%
    180 Bearish Setup Bearish Swing Setup 1.18%
    Earnings Movers Other 1.18%
    Wide Bands Range Expansion 1.18%
    Gapped Up Strength 1.18%
    Earnings Movers Other 1.18%
    Older End-of-Day Signals for MYMD ...

       Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

    Alert Time
    10 DMA Support 1 day ago
    60 Minute Opening Range Breakdown 1 day ago
    Down 1% 1 day ago
    60 Minute Opening Range Breakout 1 day ago
    Up 2% 1 day ago
    View Earlier Intraday Alerts

    Free Daily (Stock) Chart Reading

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    MYMD Chart by TradingView
    Basic chart:

    Profile

    MyMD Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, engages in the development of drug products in the targeting of aging and age-related diseases; autoimmune diseases; and chronic pain, anxiety, and sleep disorders. It commercializes MYMD-1, a novel therapeutic to impact conditions related to immunometabolic dysregulation; and SUPERA-1R, a synthetic cannabidiol that offers bioavailability and potency than botanicals. The company was incorporated in 2014 and is based in Tampa, Florida.
    Classification
    Sector: Healthcare
    Industry: Medical Instruments & Supplies
    Keywords: Medicine Pharmaceutical Immunology Health Sciences Autoimmune Disease Medication Health Care Cannabis Disorders Euphoriants Entheogens Chronic Pain Autoimmunity Drug Products Cannabidiol Age Related Diseases

    Is MYMD a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Mar 20 MyMD Pharmaceuticals® and Charles River Present Positive Data for Next Generation, Oral TNF-α Inhibitor MYMD-1® in Rheumatoid Arthritis
    Mar 8 MyMD Joins LOT Network in Effort to Protect Company and Shareholders from Patent Trolls
    Mar 2 MyMD says DEA found that its cannabinoid Supera-CBD is not a controlled substance
    Mar 2 MyMD Announces U.S. Drug Enforcement Administration (DEA) Determines Supera-CBD™ is not a Controlled Substance or Listed Chemical
    Feb 28 MyMD Pharmaceuticals® Announces Upcoming Presentation of Preclinical Rheumatoid Arthritis Data for Oral TNF-α Inhibitor MYMD-1® at the Society of Toxicology 2023 Annual Meeting
    Feb 21 MyMD Pharmaceuticals to raise $15M from current investors
    Feb 21 MyMD Announces $15 Million Offering with Existing Investors
    Dec 6 MyMD Pharmaceuticals® to Present Data on Oral TNF-a Inhibitor MYMD-1® at the British Society for Immunology (BSI) Congress 2022
    Nov 17 MyMD Pharmaceuticals® Announces Upcoming Presentation of Late-Breaking Data for MYMD-1® at the 2022 British Society for Immunology (BSI) Congress
    Nov 14 MyMD Pharmaceuticals Announces Publication of Phase 1 Data for oral TNF-alpha Inhibitor MYMD-1® in Peer-Reviewed Journal Drug Research
    See more MYMD news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 6.14
    52 Week Low 0.9
    Average Volume 500,243
    200-Day Moving Average 2.53
    50-Day Moving Average 1.96
    20-Day Moving Average 1.84
    10-Day Moving Average 1.68
    Average True Range 0.21
    RSI 46.81
    ADX 14.44
    +DI 27.65
    -DI 24.75
    Chandelier Exit (Long, 3 ATRs) 1.71
    Chandelier Exit (Short, 3 ATRs) 1.99
    Upper Bollinger Bands 2.26
    Lower Bollinger Band 1.42
    Percent B (%b) 0.36
    BandWidth 45.70
    MACD Line -0.09
    MACD Signal Line -0.07
    MACD Histogram -0.0142
    Fundamentals Value
    Market Cap 32.04 Million
    Num Shares 18.6 Million
    EPS -0.72
    Price-to-Earnings (P/E) Ratio -2.41
    Price-to-Sales 5.11
    Price-to-Book 1.79
    PEG Ratio 0.00
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 1.83
    Resistance 3 (R3) 1.83 1.79 1.81
    Resistance 2 (R2) 1.79 1.76 1.79 1.81
    Resistance 1 (R1) 1.76 1.74 1.74 1.76 1.80
    Pivot Point 1.72 1.72 1.71 1.72 1.72
    Support 1 (S1) 1.68 1.69 1.66 1.68 1.64
    Support 2 (S2) 1.64 1.67 1.64 1.63
    Support 3 (S3) 1.61 1.64 1.63
    Support 4 (S4) 1.61